Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Haematologica
|
April 4, 2024
A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia
Guru Subramanian Guru Murthy, Antoine N Saliba, Aniko Szabo, et al.
Research Square
|
March 30, 2023
Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration
Tania Jain, Hua-Ling Tsai, Hany Elmariah, et al.
Blood
|
March 19, 2025
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT
Zachariah DeFilipp, Haesook T Kim, Laura W Knight, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2020
Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation
Saurabh Chhabra, Alexis Visotcky, Marcelo C Pasquini, et al.
Blood Advances
|
December 20, 2024
A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies
Matthew S Davids, Danielle M Brander, Yesid Alvarado-Valero, et al.
Haematologica
|
July 6, 2023
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration
Tania Jain, Hua-Ling Tsai, Hany Elmariah, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Haematologica
|
April 4, 2024
A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia
Guru Subramanian Guru Murthy, Antoine N Saliba, Aniko Szabo, et al.
Research Square
|
March 30, 2023
Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration
Tania Jain, Hua-Ling Tsai, Hany Elmariah, et al.
Blood
|
March 19, 2025
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT
Zachariah DeFilipp, Haesook T Kim, Laura W Knight, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2020
Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation
Saurabh Chhabra, Alexis Visotcky, Marcelo C Pasquini, et al.
Blood Advances
|
December 20, 2024
A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies
Matthew S Davids, Danielle M Brander, Yesid Alvarado-Valero, et al.
Haematologica
|
July 6, 2023
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration
Tania Jain, Hua-Ling Tsai, Hany Elmariah, et al.
Page
of 4